Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
17 June 2021 | Story Xolisa Mnukwa | Photo Supplied
CUADS: Recognised for its efforts in human reconciliation within higher education spaces by creating and providing opportunities for students with disabilities to thrive academically.

In commemoration of Youth Month 2021, the South African government zooms in to uncover opportunities available to the South African youth, drawing more young people into the economy, and initiating various youth development and empowerment initiatives to support young people.

In line with this, the University of the Free State (UFS) Centre for Universal Access and Disability Support (CUADS) has established and implemented a number of technological and academic support measures to humanise the experiences of students with disabilities at the UFS, encouraging universal access and academic success for all students.  The ultimate aim is to have young people with disabilities employed in order to participate in the economy of South Africa.

CUADS continues the mission established when the department first opened: to become a higher-education institution support service recognised for its efforts in human reconciliation by creating and providing opportunities for students with disabilities to ultimately achieve academically, and to have an institutional culture of embracing and welcoming persons with disabilities on all three campuses of the UFS.

According to Martie Miranda, Assistant Director of CUADS and chair of the Higher and Further Education Disability Services Association, CUADS is monumental in its ability to accommodate the specific needs of students with sensory, physical, and learning disabilities, and has inspired other South African universities to enhance the qualities of their services by adapting their strategic visions to that of CUADS, which aims to operationalise and cater for the core needs of students through the UFS Integrated Transformation Plan (ITP), founded on the Strategic Policy Framework on Disability for the post-education and training sector. 

The UFS ITP assists in addressing physical barriers (accessibility to and within buildings, e.g., ramps, doorways, services, and information), attitudinal barriers (communication access, awareness and advocacy, integrated programmes to mix and learn between peers), and structural barriers (policies, flexible service delivery, and employment practices).

CUADS, in line with the UFS Division of Student Affairs (DSA), prioritises student success and plans to maintain continuous engagement with students (on an individual basis, but also per disability category) to continue the support needed to ensure student success.


News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept